logo-loader
viewCello Health PLC

Block Listing Update

/**/ link{ color: blue }visited{ color: purple } .z{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.z{}p.bo{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm}span.bm{font-size:10.0pt;font-family: "Calibri","sans-serif";color:black}p.bp{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; margin-top: 0cm; text-align: center}span.bk{font-size:10.0pt;font-family:"Calibri","sans-serif";color:black}p.bq{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top: 0cm; text-align: center}span.br{color: black; font-family: "Calibri","sans-serif"; font-size: 10.0pt; font-weight: bold}p.bs{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";margin-top:0cm;text-align:justify;background:white}span.bt{font-size:10.0pt;font-family:"Calibri","sans-serif"; color:black} p.bu{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 13.2pt}span.be{font-size:10.5pt;color:black}table.bv{width:446.55pt;border-collapse:collapse}tr.ax{height:15.0pt}td.ba{width:208.95pt;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt}p.bw{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 11.0pt}span.bc{font-size:10.0pt;color:black}td.ay{width:216.0pt;padding:0cm 5.4pt 0cm 5.4pt;height:15.0pt}p.bx{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:11.0pt;line-height:normal}td.aw{width:216.0pt;padding:0cm 5.4pt 0cm 5.4pt; height:15.0pt} td.at{width:8.0cm;padding:0cm 0cm 0cm 0cm;height:15.0pt}p.by{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-bottom:0cm;margin-bottom:.0001pt;line-height: normal}span.av{font-size:10.0pt}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";}p.bz{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; text-align: center}span.ar{font-size:10.0pt;line-height:115%;color:black}p.ca{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-align: center}table.cb{width:446.55pt;border-collapse:collapse;border:none}td.am{width:206.7pt;border:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.cc{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:3.0pt;margin-right:0cm;margin-bottom: 12.1pt;margin-left:0cm;line-height:normal} span.ao{font-size:10.0pt; color:black}td.al{width:218.25pt;border:solid windowtext 1.0pt; border-left:none;padding:0cm 5.4pt 0cm 5.4pt}td.ak{width:206.7pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}td.aj{width:218.25pt;border-top:none; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ai{width:166.15pt;border:solid windowtext 1.0pt; border-top:none;padding:0cm 5.4pt 0cm 5.4pt}td.ah{width:29.75pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ag{width:74.75pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.af{width:15.7pt;border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}td.ae{width:106.2pt;border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt; padding:0cm 5.4pt 0cm 5.4pt}p.cd{margin-top:0cm;margin-right:0cm;margin-bottom:10.0pt;margin-left:0cm;line-height:115%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:3.0pt;margin-right:0cm;margin-bottom: 11.0pt;margin-left:0cm;line-height:normal} span.ac{color:black}td.ab{border:none} /**/
RNS Number : 5159K
Cello Health PLC
14 December 2018
 

14 December 2018

Cello Health plc

("Cello" or the "Company")

Block Listing Update

Further to the announcement by the Company on 5 June 2018, the Company announces that a total of 51,988 new ordinary shares of 10p each in the share capital of the Company ("Ordinary Shares") have been issued and allotted since that date pursuant to the Company's PSP Option Scheme 2010, its Approved Share Option Plan 2009 and its Unapproved Scheme 2010 and admitted to trading in accordance with the block listing applied for at that time (the "Block Listing"). An update in accordance with Schedule 6 of the AIM Rules for Companies is set out below.

Enquires

Cello Health

020 7812 8460

Mark Scott, Chief Executive


Mark Bentley, Finance Director




Cenkos Securities

  020 7397 8900

Mark Connelly
Harry Hargreaves


 

BLOCK LISTING SIX MONTHLY RETURN

 

Name of applicant:

Cello Health plc

Name of scheme:

PSP Option Scheme 2010, Approved Share Option Plan 2009 and Unapproved Scheme 2010

Period of return:

From:

31 May 2018

To:

31 November 2018

Balance of unallotted securities under scheme(s) from previous return:

663,596

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

-

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

(51,988)

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

611,608

Name of contact:

Mark Bentley, Group Finance Director

Telephone number of contact:

020 7812 8460

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRZMMMZLDZGRZG

Quick facts: Cello Health PLC

Price: 130

Market: AIM
Market Cap: £138.6 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Cello Health reports good growth in profits and strong cash flow

Cello Health PLC's (LON:CLL) Mark Scott tells Proactive London they've seen good growth in profits and strong cash flow for the first half of the year said that he's confident about the rest of the year too. The group delivered net revenue of £54.5mln for the first six months of the year,...

on 18/9/19

RNS

Holding(s) in Company

1 week, 1 day ago

Total Voting Rights

1 week, 2 days ago

Total Voting Rights

on 7/10/19

Disposal

on 2/10/19

Interim Results

on 18/9/19

Acquisition of ISS

on 16/8/19